SKI Market

Indian Indices

Nifty

25,891.40 22.80
(0.09%)

Sensex

84,556.40 130.06
( 0.15%)

Bank Nifty

58,078.05 70.85
( 0.12%)

Nifty IT

36,078.65 778.90
( 2.21%)

Global Indices

Nasdaq

46,613.81 -331.93
(-0.71%)

Dow Jones

6,721.09 -35.26
(-0.52%)

Hang Seng

48,675.08 -632.71
(-1.28%)

Nikkei 225

9,515.00 88.01
(0.93%)

Forex

USD-INR

87.98 0.08
(0.09%)

EUR-INR

102.21 -0.23
(-0.23%)

GBP-INR

117.73 -0.22
(-0.19%)

JPY-INR

0.58 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astrazeneca Pharma India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

506820

INE203A01020

308.14

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ASTRAZEN

109.96

23252.88

EPS(TTM)

Face Value()

Div & Yield %

84.59

0.34

Back

Reliance Industries Ltd - Consolidated And Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025

Oct 17,2025

Please find attached Consolidated and Standalone Unaudited Financial Results for the quarter and half year ended September 30 2025

25,891.40 22.80 (0.09%)

84,556.40 130.06 ( 0.15%)

58,078.05 70.85 ( 0.12%)

36,078.65 778.90 ( 2.21%)

46,613.81 -331.93 (-0.71%)

6,721.09 -35.26 (-0.52%)

48,675.08 -632.71 (-1.28%)

9,515.00 88.01 (0.93%)

87.98 0.08 (0.09%)

102.21 -0.23 (-0.23%)

117.73 -0.22 (-0.19%)

0.58 0.00 (-0.48%)